Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7K Sell
167
-46
-22% -$3.43K ﹤0.01% 978
2026
Q1
$15.7K Buy
213
+187
+719% +$14.8K ﹤0.01% 865
2025
Q4
$2.13K Hold
26
﹤0.01% 982
2025
Q3
$1.93K Hold
26
﹤0.01% 1011
2025
Q2
$1.76K Buy
+26
New +$1.6K ﹤0.01% 1009
2023
Q2
Sell
-23
Closed -$886 1060
2023
Q1
$886 Sell
23
-247
-91% -$10.4K ﹤0.01% 910
2022
Q4
$10.5K Buy
270
+7
+3% +$277 ﹤0.01% 652
2022
Q3
$9K Buy
263
+113
+75% +$4.45K ﹤0.01% 647
2022
Q2
$6K Buy
150
+37
+33% +$1.54K ﹤0.01% 727
2022
Q1
$5K Hold
113
﹤0.01% 780
2021
Q4
$5K Buy
+113
New +$5.49K ﹤0.01% 758

Other funds holding SF

CVA Family Office's SF Position: Q2 2026 in Review

CVA Family Office reduced its Stifel (SF) stake by 22% in Q2 2026, selling an estimated $3.43K and leaving 167 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #978.

CVA Family Office first reported a position in SF in Q4 2021 and has held it in 11 quarters since. The position peaked at $15.7K in Q1 2026. 592 funds tracked by Wall St. Rank hold SF as of Q2 2026.

  • CVA Family Office held 167 shares of Stifel worth $11.7K as of Q2 2026.
  • CVA Family Office sold 46 Stifel shares in Q2 2026, an estimated $3.43K.
  • Stifel made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #978 holding.
  • CVA Family Office first reported a position in Stifel in Q4 2021 and has held it in 11 quarters since.
  • CVA Family Office's Stifel position peaked at $15.7K in Q1 2026.
  • 592 funds tracked by Wall St. Rank held Stifel as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.